Pten loss and PI3K/AKT dysregulation are substantially associated with advanced prostate cancer and castration-resistant prostate cancer, indicating a potential interaction between epithelial–mesenchymal transition and common prostate cancer driver mutations [27]. This evidence concerns the gene PTEN and prostate carcinoma.